Platelet-associated PF-4 as a biomarker of early tumor growth. - Wikidata - awgldk - TriplyDB

Platelet-associated PF-4 as a biomarker of early tumor growth.

Platelet-associated PF-4 as a biomarker of early tumor growth.

http://www.wikidata.org/entity/Q33301427

about

An orally delivered small-molecule formulation with antiangiogenic and anticancer activity Metronomic chemotherapy: an attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance Application of proteomics to soft tissue sarcomas Mass homozygotes accumulation in the NCI-60 cancer cell lines as compared to HapMap Trios, and relation to fragile site location.Platelets actively sequester angiogenesis regulators.Micronutrients attenuate progression of prostate cancer by elevating the endogenous inhibitor of angiogenesis, platelet factor-4 Isolation and proteomic analysis of platelets by SELDI-TOF MS.The role of platelets in tumour growth.Combination antiangiogenic therapy in advanced breast cancer: a phase 1 trial of vandetanib, a VEGFR inhibitor, and metronomic chemotherapy, with correlative platelet proteomics Chitosan-based thermoreversible hydrogel as an in vitro tumor microenvironment for testing breast cancer therapies.Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis.The platelet proteome.Activation of p38-MAPK by CXCL4/CXCR3 axis contributes to p53-dependent intestinal apoptosis initiated by 5-fluorouracil Potential serum biomarkers for glioblastoma diagnostic assessed by proteomic approaches.The role of platelet factor 4 in local and remote tissue damage in a mouse model of mesenteric ischemia/reperfusion injury.Elevated expression of CXC chemokines in pediatric osteosarcoma patients Control of angiogenesis by galectins involves the release of platelet-derived proangiogenic factors Generation and Characterization of a New Monoclonal Antibody Against CXCL4.Normal Wound Healing and Tumor Angiogenesis as a Game of Competitive Inhibition.CXCL4 mediates tumor regrowth after chemotherapy by suppression of antitumor immunity Tumour dormancy and clinical implications in breast cancer.Role of platelet chemokines, PF-4 and CTAP-III, in cancer biology.Genetic dissection of platelet function in health and disease using systems biology.Platelet proteome and tumor dormancy: can platelets content serve as predictive biomarkers for exit of tumors from dormancy?The platelet contribution to cancer progression.Inhibition of angiogenesis and the angiogenesis/invasion shift.Platelet-associated angiogenesis regulating factors: a pharmacological perspective.Tumor endothelial markers as a target in cancer.Role of platelets in inflammation and cancer: novel therapeutic strategies.Tumor vascularity in prostate cancer: an update on circulating endothelial cells and platelets as noninvasive biomarkers.Augmenting tendon and ligament repair with platelet-rich plasma (PRP).Cancer-immune equilibrium: questions unanswered Platelets and their microparticles as key players in pathophysiological responses.Platelets in cancer metastasis: To help the "villain" to do evil.Carbon nanotubes: a novel material for multifaceted applications in human healthcare.Proteome analysis of sheep B lymphocytes in the course of bovine leukemia virus-induced leukemia.Fluorescence nanoscopy of platelets resolves platelet-state specific storage, release and uptake of proteins, opening up future diagnostic applications.Tumors stimulate platelet delivery of angiogenic factors in vivo: an unexpected benefit.The prognostic significance of circulating serum amyloid A and CXC chemokine ligand 4 in osteosarcoma.Current status of proteomics of soft tissue sarcomas.

P2860

Q24649290-1FEFD829-090C-4921-B7B5-25ED9EBC2A74 Q27023579-AA26AF14-5E70-4CF2-8475-D218132CD55F Q28385995-5ED1D8FE-60ED-4B92-9A7E-BD51E299A468 Q31048838-B987A7C1-A29E-4437-9E26-04BB442A1DB1 Q33387520-9BCE7B9B-1D4F-4326-950C-EC2EF2F8C64C Q33595280-8F6716E0-A8B9-4FB5-9DCB-9CF762C0044E Q33803553-B07C643F-40A3-48FA-A393-228EE7970B64 Q33803558-7D68DA2D-28E5-4D27-A01F-C83FDA46B838 Q33803564-CB1647E9-1DF4-4F52-87BE-07D277F351D5 Q33894643-0EC75EF3-3C8C-4E9A-82B7-95376D4FE888 Q33896683-60537F7F-A5F3-49DC-8914-A4E84D2A91F8 Q33904184-7B7AEDEE-DAB0-402B-8FAD-129006C4292D Q33990012-ECADE363-3E20-44B8-BFF3-C2F54DE5779A Q34305848-0A27482F-A8FE-4692-9F14-9FF38367F214 Q34335768-617C29CD-84F4-4446-9137-5FE8E0EF9DCB Q34380220-54BB6C2C-CFEF-4CF3-879E-319279A5A05C Q35161608-DD5BC68A-A5E1-41C9-AFDB-D1832AA1F63A Q35540003-D9FC0DAF-CB9D-4A56-9D44-BA93F4E8525D Q36217588-A3631A94-D366-4D4B-AE8A-CADE27533A41 Q36843770-E75A17D7-67D8-49CD-BEA3-590C14151139 Q36863179-52613A42-8C4B-4E0D-8A33-74BC330393CC Q36960001-EC6B1A81-BD09-47B6-A32A-7509E70C328F Q37156517-882981B7-CE00-43BF-BAFE-240880957404 Q37328356-CCAAC510-3ED2-494B-B1B7-3FD9DB9F4884 Q37805788-25F7F4FB-8FAA-4884-AB73-F3300D1D0FF7 Q37958925-80A120AB-8B37-4A76-AA79-16B095A7BADC Q38003425-31081742-AAE6-4FD4-9127-45B0027CFF79 Q38043525-E3D2A1E0-404A-4707-A3EF-DB50002EA8C4 Q38151957-1F07DC60-F6DB-4541-996C-492D700A4415 Q38165245-20F59FE3-CD1D-4E48-9E78-C864B8FE73F2 Q38173764-B2609531-EF6D-460C-90FB-74EE85773F22 Q38366247-F08795E5-DDB4-40F3-B425-4374D5063337 Q38543319-E9539DBD-D5EA-4460-98D8-0EFF036DFABE Q38584175-E1423298-5035-4436-991F-0926B63F80A9 Q38795672-449B435A-65AE-408F-A43C-039034589186 Q38823622-0457731C-0CA5-48C9-A42E-7137EC312CBA Q39513728-6FC81FEF-3E35-4123-B476-19A268090A95 Q43198623-D9FCC9FC-20F4-4DB3-976E-6687B9DD4343 Q45768840-C30D928C-AF8D-442F-BAB0-622818F429C7 Q47640603-EDA345F2-FD41-4064-8ECD-DD5DEBAC8AA3

P2860

Platelet-associated PF-4 as a biomarker of early tumor growth.

http://www.wikidata.org/entity/Q33301427

description

2007 nî lūn-bûn

@nan

2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Platelet-associated PF-4 as a biomarker of early tumor growth.

@ast

Platelet-associated PF-4 as a biomarker of early tumor growth.

@en

Platelet-associated PF-4 as a biomarker of early tumor growth.

@nl

type

label

Platelet-associated PF-4 as a biomarker of early tumor growth.

@ast

Platelet-associated PF-4 as a biomarker of early tumor growth.

@en

Platelet-associated PF-4 as a biomarker of early tumor growth.

@nl

prefLabel

Platelet-associated PF-4 as a biomarker of early tumor growth.

@ast

Platelet-associated PF-4 as a biomarker of early tumor growth.

@en

Platelet-associated PF-4 as a biomarker of early tumor growth.

@nl

P1433

Q33301427-34793DC7-0BC1-4BF9-AF75-E0B30B364022

P1476

Q33301427-2C24C9D0-1244-4978-AD4D-C2C2D591C1FD

P2093

Q33301427-03D834FE-A5E5-40AA-81B6-823B4AD3817A

Q33301427-0BB7398E-46B7-4F98-B39F-EA58EC432057

Q33301427-0E599668-7783-4EDE-8CB0-CD5D870F8575

Q33301427-143FC901-3A52-45F5-90B9-971266A33757

Q33301427-26B39BD5-65CE-4832-B520-DBFB2A838279

Q33301427-45CF21DC-510C-4B1E-8615-8FF09DDD4F40

Q33301427-63BE5102-22BE-4DE2-9E96-146ED89D3A1A

Q33301427-6637D8E2-2813-4FEC-9DA0-267501EF6EBE

Q33301427-AAF4C56D-9425-4489-93EB-885A5E137E14

Q33301427-B2E50798-C095-4F2A-A1A6-0EEABF405C73

P304

Q33301427-4119D032-95AE-4923-881D-8473F5D14BCB

P31

Q33301427-5F456BF0-1E3B-4561-BF07-46FB8C55BD2F

P356

Q33301427-B34C8CC5-1C81-4409-B046-4B1FCA5235C4

P407

Q33301427-9D5A1626-E658-4C74-9327-BA6F1B38A32B

P433

Q33301427-6F37D1CE-460E-47EA-81A9-87974A2655A6

P478

Q33301427-F209757D-24D9-45DF-991C-DC3EFC6109B4

P577

Q33301427-11BB2705-390E-4EA6-BF66-65674563ED37

P5875

Q33301427-3793D0DE-319F-4F52-85A4-70B75CBC2A1F

P698

Q33301427-A1D0449F-1493-41E4-A065-D36F2B5766DF

P921

Q33301427-0DCE476F-B804-4376-B679-E902B1578392

P356

BLOOD-2007-04-084798

P1433

P1476

Platelet-associated PF-4 as a biomarker of early tumor growth.

@en

P2093

Abdo Abou-Slaybi

http://www.w3.org/2001/XMLSchema#string

David Cervi

http://www.w3.org/2001/XMLSchema#string

Elise Bender

http://www.w3.org/2001/XMLSchema#string

George N Naumov

http://www.w3.org/2001/XMLSchema#string

Giannoula L Klement

http://www.w3.org/2001/XMLSchema#string

Jon Peterson

http://www.w3.org/2001/XMLSchema#string

Joseph E Italiano

http://www.w3.org/2001/XMLSchema#string

Judah Folkman

http://www.w3.org/2001/XMLSchema#string

Nandita Bhattacharya

http://www.w3.org/2001/XMLSchema#string

Nava Almog

http://www.w3.org/2001/XMLSchema#string

P304

1201-1207

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2007-04-084798

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5931047

http://www.w3.org/2001/XMLSchema#string

P698

17914028

http://www.w3.org/2001/XMLSchema#string

P921